Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Clasificación en acciones #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Precio por acción
$481.73
Capitalización bursátil
$377.65B
Cambio (1 día)
-0.96%
Cambio (1 año)
50.07%
País
CH
Comercio Roche Holding AG (RO)

Categoría

Ganancias de Roche Holding AG (RO)
Ganancias en Dec 2025 TTM: $21.39B
Secondo gli ultimi rapporti finanziari di Roche Holding AG, gli utili attuali della società sono $21.39B. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Roche Holding AG desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$33.59B 57.07%
US
$25.20B 17.80%
US
$8.70B -59.33%
US
$5.95B -72.19%
US
$16.38B -23.42%
CH